{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:43:22Z","timestamp":1788270202635,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>\n                    Observational studies have shown an association between hypertension and atrial fibrillation (AF). Aggressive blood pressure management in patients with known AF reduces overall arrhythmia burden, but it remains unclear whether hypertension is causative for AF. To address this question, this study explored the relationship between genetic predictors of blood pressure and risk of AF. We secondarily explored the relationship between genetically proxied use of antihypertensive drugs and risk of AF. Two-sample Mendelian randomization was performed using an inverse-variance weighted meta-analysis with weighted median Mendelian randomization and Egger intercept tests performed as sensitivity analyses. Summary statistics for systolic blood pressure, diastolic blood pressure, and pulse pressure were obtained from the International Consortium of Blood Pressure and the UK Biobank discovery analysis and AF from the 2018 Atrial Fibrillation Genetics Consortium multiethnic genome-wide association studies. Increases in genetically proxied systolic blood pressure, diastolic blood pressure, or pulse pressure by 10 mm\u2009Hg were associated with increased odds of AF (systolic blood pressure: odds ratio [OR], 1.17 [95% CI, 1.11\u20131.22];\n                    <jats:italic>P<\/jats:italic>\n                    =1\u00d710\n                    <jats:sup>\u221211<\/jats:sup>\n                    ; diastolic blood pressure: OR, 1.25 [95% CI, 1.16\u20131.35];\n                    <jats:italic>P<\/jats:italic>\n                    =3\u00d710\n                    <jats:sup>\u22128<\/jats:sup>\n                    ; pulse pressure: OR, 1.1 [95% CI, 1.0\u20131.2];\n                    <jats:italic>P<\/jats:italic>\n                    =0.05). Decreases in systolic blood pressure by 10 mm\u2009Hg estimated by genetic proxies of antihypertensive medications showed calcium channel blockers (OR, 0.66 [95% CI, 0.57\u20130.76];\n                    <jats:italic>P<\/jats:italic>\n                    =8\u00d710\n                    <jats:sup>\u22129<\/jats:sup>\n                    ) and \u03b2-blockers (OR, 0.61 [95% CI, 0.46\u20130.81];\n                    <jats:italic>P<\/jats:italic>\n                    =6\u00d710\n                    <jats:sup>\u22124<\/jats:sup>\n                    ) decreased the risk of AF. Blood pressure\u2013increasing genetic variants were associated with increased risk of AF, consistent with a causal relationship between blood pressure and AF. These data support the concept that blood pressure reduction with calcium channel blockade or \u03b2-blockade could reduce the risk of AF.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.16191","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T05:01:12Z","timestamp":1609736472000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation"],"prefix":"10.1161","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-6925","authenticated-orcid":true,"given":"Matthew C.","family":"Hyman","sequence":"first","affiliation":[{"name":"From the Division of Cardiovascular Medicine (M.C.H., M.G.L., F.E.M.), University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-9932","authenticated-orcid":true,"given":"Michael G.","family":"Levin","sequence":"additional","affiliation":[{"name":"From the Division of Cardiovascular Medicine (M.C.H., M.G.L., F.E.M.), University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA (M.G.L., S.M.D.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health (D.G.), Imperial College London, United Kingdom"},{"name":"Department of Medicine, Centre for Pharmacology and Therapeutics, Hammersmith Campus (D.G.), Imperial College London, United Kingdom"},{"name":"Department of Genetics, Novo Nordisk Research Centre Oxford, Old Road Campus, United Kingdom (D.G.)"},{"name":"Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George\u2019s, University of London, United Kingdom (D.G.)"},{"name":"Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George\u2019s University Hospitals NHS Foundation Trust, London, United Kingdom (D.G.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venexia M.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Surgery (V.M.W., S.M.D.), University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Medical Research Council Integrative Epidemiology Unit (V.M.W., N.D.), University of Bristol, United Kingdom"},{"name":"Bristol Medical School: Population Health Sciences (V.M.W.), University of Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-3659","authenticated-orcid":true,"given":"Marios K.","family":"Georgakis","sequence":"additional","affiliation":[{"name":"Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany (M.K.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Davies","sequence":"additional","affiliation":[{"name":"Medical Research Council Integrative Epidemiology Unit (V.M.W., N.D.), University of Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7962-9423","authenticated-orcid":true,"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[{"name":"From the Division of Cardiovascular Medicine (M.C.H., M.G.L., F.E.M.), University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-1632","authenticated-orcid":true,"given":"Scott M.","family":"Damrauer","sequence":"additional","affiliation":[{"name":"Department of Surgery (V.M.W., S.M.D.), University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA (M.G.L., S.M.D.)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000041"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.028"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510350050036"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.009035"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eun369"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07683"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.04.062"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.10.068"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)10327-1"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.020"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpv172"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.14766"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.026857"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2016.05.007"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.589531"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euv021"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0205-x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0133-9"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21998"},{"key":"e_1_3_4_22_2","unstructured":"University of Bristol. MRC IEU UK Biobank GWAS pipeline version 2. https:\/\/data.Bris.Ac.Uk\/data\/dataset\/pnoat8cxo0u52p6ynfaekeigi. Accessed March 2020."},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215597579"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038814"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz155"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24277"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120758"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210394459"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.7.709"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature10405"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-019-0133-y"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000257123.95372.ab"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.05.010"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072416"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.025"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.25.6.1155"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-2-201001190-00005"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.16191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:37:35Z","timestamp":1715582255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.16191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.16191"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.16191","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.26.20162339","asserted-by":"object"}]},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"2020-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}